not tagged
not tagged
['cart,(-cartitude)', 'lymsm']
#eha22 #lymsm thieblemont: median os nr yet. os at 1yr 56.9%. those achieving mrd negativity by ctdna analysis (45.8%) have excellent pfs. looks like this will be a good option for post-cart progression; will be interesting to see in combination therapy. 
Assoc Professor, UCSF hematology/BMT. Translational researcher interested in leukemia, MDS, MRD, post-HCT relapse, GVHD, & immune recon. Photos: pyknosis (IG)